LSTA FY 2013 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+2.4% YoY

Gross Profit

$2M11.7% margin

Operating Income

-$37M-250.9% margin

Net Income

-$39M-265.7% margin

EPS (Diluted)

$-285.29

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$30M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$90M

Total Liabilities

$28M

Stockholders' Equity

$63M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$14M	+2.4%
Gross Profit	$2M	$2M	-27.7%
Operating Income	-$37M	-$30M	-21.1%
Net Income	-$39M	-$55M	+28.8%